Search Results 91-100 of 16886 for Hodgkin disease
About this study. The purpose of this study is to compare the gut microbiome (GMB) profile of patients with untreated non-Hodgkin lymphoma (NHL) and Hodgkin ...
Brentuximab injection is used to treat Hodgkin lymphoma, systemic anaplastic large cell lymphoma ... Liver disease, mild—Use with caution. The effects may ...
... Hodgkin lymphoma that has returned after a period of improvement. ... Participant eligibility includes age, gender, type and stage of disease, and previous ...
The purpose of this study is to compare the gut microbiome (GMB) profile of patients with untreated non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) and ...
... disease after stem cell transplant. Ruxolitinib phosphate may stop the ... Hodgkin or Hodgkin lymphoma. A Study to Evaluate Clinical Transplant-Related ...
Lenalidomide may stop the growth of non-Hodgkin lymphoma by blocking blood flow to the cancer. ... Co-morbid systemic illnesses or other severe concurrent disease ...
- For Non-Hodgkin or Hodgkin Lymphoma and histiocytic/dendritic cell: - Measurable disease is defined as measurable by computed tomography (CT) (dedicated ...
Lenalidomide may stop the growth of non-Hodgkin lymphoma by blocking blood flow to the cancer. Giving lenalidomide together with rituximab and bendamustine ...
This phase I/II trial studies the best dose and side effects of dendritic cell therapy, cryosurgery and pembrolizumab in treating patients with non-Hodgkin ...
... Hodgkin lymphoma (NHL), and in previously ... lymphoma);; Primary DLBCL ... disease (including obstructive pulmonary disease and history of bronchospasm) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.